Tadalafil-associated priapism

Urology

Volumn 66, Issue 2, 2005, Pages 432.e15-432.e18

  King, Stephen H ^a,b   Hallock, Maralyn ^a   Strote, Jared ^a   Wessells, Hunter ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL;

ADULT; ARTICLE; CASE REPORT; COMPRESSION; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; ISCHEMIA; MALE; MUSCLE HYPOTONIA; PENIS ERECTION; POSTOPERATIVE PERIOD; PRIAPISM; PRIORITY JOURNAL; SHUNTING;

EID: 23744436111     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.02.019     Document Type: Article

References (7)

1. C.C. Carson, J. Rajfer, I. Eardley The efficacy and safety of tadalafil an update BJU Int 93 2004 1276 1281
2. A.D. Seftel, S.K. Wilson, P.M. Knapp The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction J Urol 172 2004 652 657
3. R.L. Sur, C.J. Kane Sildenafil citrate-associated priapism Urology 55 2000 950
4. T. Aoyagi, K. Hayakawa, K. Miyaji Sildenafil induced priapism Bull Tokyo Dent Coll 40 1999 215 274
5. R.G. Nixon, J.L. O'Connor, D.F. Milam Efficacy of shunt surgery for refractory low flow priapism a report on the incidence of failed detumescence and erectile dysfunction J Urol 170 2003 883 886
6. M.A. Blount, A. Beasley, R. Zoraghi Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation Mol Pharmacol 66 2004 144 152
7. H. Porst IC351 (tadalafil, Cialis) update on clinical experience Int J Impot Res 14 suppl 1 2002 S57 S64